Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Assessing Four Quality Indicators for Multiple Sclerosis Management Through Patient-Reported Data.
A rapid and versatile method for the isolation, purification and cryogenic storage of Schwann cells from adult rodent nerves.
Assessment of severity of neurogenic bowel dysfunction in chronic patients with a simple 1-item questionnaire (PGI-S).
Three-dimensional X-ray visualization of axonal tracts in mouse brain hemisphere.
The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis.
RAE-1 expression is induced during experimental autoimmune encephalomyelitis and is correlated with microglia cell proliferation.
Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.
Role of IL-33 and ST2 signalling pathway in multiple sclerosis: expression by oligodendrocytes and inhibition of myelination in central nervous system.
Development of rheumatoid arthritis during treatment of multiple sclerosis with interferon beta 1-a. Coincidence of two conditions or a complication of treatment: A case report.
A new dawn for genetic association studies in multiple sclerosis.
A decade of natalizumab and PML: Has there been a tacit transfer of risk acceptance?
Bilateral abducens nerve palsy in an infant case of fulminant acute disseminated encephalomyelitis: a case report.
CIDP presenting as recurrent severe back pain without weakness or sensory loss.
DNA damage in the oligodendrocyte lineage and its role in brain aging.
The Added Value of Family Material in the Discovery of Multiple Sclerosis Genes.
TLR4 Deficiency Impairs Oligodendrocyte Formation in the Injured Spinal Cord.
Monooxygenase substrates mimic flavin to catalyze cofactorless oxygenations.
Predictive cytokine biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis.
Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Nanocarriers as Tools in Delivering Active Compounds for Immune System Related Pathologies.
Is size an essential criterion to define tumefactive plaque? MR features and clinical correlation in multiple sclerosis.
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis.
In vitro evaluation of physiologically relevant concentrations of teriflunomide on activation and proliferation of primary rodent microglia.
Adipose-Derived Cells (Stromal Vascular Fraction) Transplanted for Orthopedical or Neurological Purposes: Are They Safe Enough?
USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation.
Pages
« first
‹ previous
…
832
833
834
835
836
837
838
839
840
…
next ›
last »